Monarch Private Capital, (“Monarch”) and Generate Capital, PBC (“Generate”) today announced the closing of a 104 megawatt (MW) energy investment portfolio.

TAMPA, Fla. — Generac, a leading manufacturer of generators, expects residential demand to continue rising in storm impacted areas, and its hiring hundreds of employees as a result. Tampa Bay area ...

"In theory, this protects ordinary ratepayers from shouldering the cost of industrial-scale electricity demand. In practice, ...

Generac settles construction-site explosion suit for $206M Generac stock spikes on potential for data center products Generac ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...